ArticleRSC advances2023
The impact of silver nanoclay functionalisation on optical and electrochemical properties.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
- Silver Nanoclay Human Albumin Serum Composite Electrochemical Biosensor for Quantification of Zidovudine in Tablets.Pharmaceutical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three different fractions of nanoclay (nanomer 1.44P) were functionalised with Ag forming silver nanoclay composites (Ag/nanomer 1.44P). The optical and electrochemical properties of the functionalised nanoclay were studied. Optical, morphology, and electrochemical techniques were used for the characterisation of the synthesised Ag/nanomer 1.44P nanocly composites. The presence and the absence of functional groups observed in the FTIR spectrum of Ag/nanomer 1.44P, compared with those found in the spectra of silver and pure nanomer 1.44P prove that a reaction occurred, thus a successful functionalisation of nanomer 1.44P nanoclay with silver. The XRD data of all composites showed four diffraction peaks within the silver spectrum range, with the intensity of silver decreasing with increasing concentration of nanomer 1.44P. SEM represented well-dispersed particles of different shapes with average particle sizes of 2.5, 27.5, and 5 nm with the enhanced concentration of nanomer 1.44P nanoclay. The decrease in diffusion coefficient values from 4.26 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.